Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Melanoma cell expression of CD200 inhibits tumor formation and lung metastasis via inhibition of myeloid cell functions.

Talebian F, Liu JQ, Liu Z, Khattabi M, He Y, Ganju R, Bai XF.

PLoS One. 2012;7(2):e31442. doi: 10.1371/journal.pone.0031442. Epub 2012 Feb 3.

2.

A Critical Role for CD200R Signaling in Limiting the Growth and Metastasis of CD200+ Melanoma.

Liu JQ, Talebian F, Wu L, Liu Z, Li MS, Wu L, Zhu J, Markowitz J, Carson WE 3rd, Basu S, Bai XF.

J Immunol. 2016 Aug 15;197(4):1489-97. doi: 10.4049/jimmunol.1600052. Epub 2016 Jul 6.

PMID:
27385779
3.

Tumor expression of CD200 inhibits IL-10 production by tumor-associated myeloid cells and prevents tumor immune evasion of CTL therapy.

Wang L, Liu JQ, Talebian F, El-Omrani HY, Khattabi M, Yu L, Bai XF.

Eur J Immunol. 2010 Sep;40(9):2569-79. doi: 10.1002/eji.201040472.

4.

The role of CD200-CD200R in tumor immune evasion.

Liao KL, Bai XF, Friedman A.

J Theor Biol. 2013 Jul 7;328:65-76. doi: 10.1016/j.jtbi.2013.03.017. Epub 2013 Mar 28.

PMID:
23541619
5.

Immune modulation by melanoma and ovarian tumor cells through expression of the immunosuppressive molecule CD200.

Siva A, Xin H, Qin F, Oltean D, Bowdish KS, Kretz-Rommel A.

Cancer Immunol Immunother. 2008 Jul;57(7):987-96.

PMID:
18060403
6.

Regulation of myeloid cell function through the CD200 receptor.

Jenmalm MC, Cherwinski H, Bowman EP, Phillips JH, Sedgwick JD.

J Immunol. 2006 Jan 1;176(1):191-9.

7.

Characterization of the CD200 receptor family in mice and humans and their interactions with CD200.

Wright GJ, Cherwinski H, Foster-Cuevas M, Brooke G, Puklavec MJ, Bigler M, Song Y, Jenmalm M, Gorman D, McClanahan T, Liu MR, Brown MH, Sedgwick JD, Phillips JH, Barclay AN.

J Immunol. 2003 Sep 15;171(6):3034-46.

8.

Is the CD200/CD200 receptor interaction more than just a myeloid cell inhibitory signal?

Minas K, Liversidge J.

Crit Rev Immunol. 2006;26(3):213-30. Review.

9.

Comparison of immunity in mice cured of primary/metastatic growth of EMT6 or 4THM breast cancer by chemotherapy or immunotherapy.

Gorczynski RM, Chen Z, Erin N, Khatri I, Podnos A.

PLoS One. 2014 Nov 19;9(11):e113597. doi: 10.1371/journal.pone.0113597. eCollection 2014.

10.

Dissection of agonistic and blocking effects of CD200 receptor antibodies.

Akkaya M, Aknin ML, Akkaya B, Barclay AN.

PLoS One. 2013 May 14;8(5):e63325. doi: 10.1371/journal.pone.0063325. Print 2013.

11.

The immunosuppressive surface ligand CD200 augments the metastatic capacity of squamous cell carcinoma.

Stumpfova M, Ratner D, Desciak EB, Eliezri YD, Owens DM.

Cancer Res. 2010 Apr 1;70(7):2962-72. doi: 10.1158/0008-5472.CAN-09-4380. Epub 2010 Mar 23.

12.

CD200-CD200R signaling suppresses anti-tumor responses independently of CD200 expression on the tumor.

Rygiel TP, Karnam G, Goverse G, van der Marel AP, Greuter MJ, van Schaarenburg RA, Visser WF, Brenkman AB, Molenaar R, Hoek RM, Mebius RE, Meyaard L.

Oncogene. 2012 Jun 14;31(24):2979-88. doi: 10.1038/onc.2011.477. Epub 2011 Oct 24.

PMID:
22020332
13.

Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes.

Najar M, Raicevic G, Jebbawi F, De Bruyn C, Meuleman N, Bron D, Toungouz M, Lagneaux L.

Immunol Lett. 2012 Aug 30;146(1-2):50-6. doi: 10.1016/j.imlet.2012.04.017. Epub 2012 May 2.

PMID:
22575528
14.

Chronic infection drives expression of the inhibitory receptor CD200R, and its ligand CD200, by mouse and human CD4 T cells.

Caserta S, Nausch N, Sawtell A, Drummond R, Barr T, Macdonald AS, Mutapi F, Zamoyska R.

PLoS One. 2012;7(4):e35466. doi: 10.1371/journal.pone.0035466. Epub 2012 Apr 9.

15.

The expressions of CD200 and CD200R molecules on myeloid and lymphoid dendritic cells in pre-eclampsia and normal pregnancy.

Darmochwal-Kolarz DA, Kludka-Sternik M, Chmielewski T, Kolarz B, Rolinski J, Leszczynska-Gorzelak B, Oleszczuk J.

Am J Reprod Immunol. 2012 Jun;67(6):474-81. doi: 10.1111/j.1600-0897.2012.01126.x. Epub 2012 Mar 29.

PMID:
22462561
16.

Evidence of a role for CD200 in regulation of immune rejection of leukaemic tumour cells in C57BL/6 mice.

Gorczynski RM, Chen Z, Hu J, Kai Y, Lei J.

Clin Exp Immunol. 2001 Nov;126(2):220-9.

17.
18.
19.

Bidirectional effect of CD200 on breast cancer development and metastasis, with ultimate outcome determined by tumor aggressiveness and a cancer-induced inflammatory response.

Erin N, Podnos A, Tanriover G, Duymuş Ö, Cote E, Khatri I, Gorczynski RM.

Oncogene. 2015 Jul;34(29):3860-70. doi: 10.1038/onc.2014.317. Epub 2014 Sep 29.

PMID:
25263452
20.

The inhibitory CD200R is differentially expressed on human and mouse T and B lymphocytes.

Rijkers ES, de Ruiter T, Baridi A, Veninga H, Hoek RM, Meyaard L.

Mol Immunol. 2008 Feb;45(4):1126-35. Epub 2007 Aug 21.

PMID:
17714785

Supplemental Content

Support Center